747 related articles for article (PubMed ID: 28239999)
41. Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
Batash R; Asna N; Schaffer P; Francis N; Schaffer M
Curr Med Chem; 2017; 24(27):3002-3009. PubMed ID: 28521700
[TBL] [Abstract][Full Text] [Related]
42. microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)-Recent Literature Review.
Makowska M; Smolarz B; Romanowicz H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834933
[TBL] [Abstract][Full Text] [Related]
43. MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.
Mercatelli N; Galardi S; Ciafrè SA
Int Rev Cell Mol Biol; 2017; 333():269-323. PubMed ID: 28729027
[TBL] [Abstract][Full Text] [Related]
44. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
45. Altered Elemental Distribution in Male Rat Brain Tissue as a Predictor of Glioblastoma Multiforme Growth-Studies Using SR-XRF Microscopy.
Planeta K; Setkowicz Z; Czyzycki M; Janik-Olchawa N; Ryszawy D; Janeczko K; Simon R; Baumbach T; Chwiej J
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054889
[TBL] [Abstract][Full Text] [Related]
46. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
Gainer JL; Sheehan JP; Larner JM; Jones DR
J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
[TBL] [Abstract][Full Text] [Related]
47. Quality of Glioblastoma Multiforme (GBM) Resources Available on the Internet.
Yang F; Ingledew PA
J Cancer Educ; 2022 Dec; 37(6):1598-1605. PubMed ID: 33770375
[TBL] [Abstract][Full Text] [Related]
48. The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review.
Mohtashami E; Shafaei-Bajestani N; Mollazadeh H; Mousavi SH; Jalili-Nik M; Sahebkar A; Afshari AR
Curr Drug Metab; 2020; 21(8):564-578. PubMed ID: 32664839
[TBL] [Abstract][Full Text] [Related]
49. microRNA-181d associated with the methylation status of the MGMT gene in Glioblastoma multiforme cancer stem cells submitted to treatments with ionizing radiation and temozolomide.
Lizarte Neto FS; Rodrigues AR; Trevisan FA; de Assis Cirino ML; Matias CCMS; Pereira-da-Silva G; Peria FM; Tirapelli DPDC; Carlotti CG
Brain Res; 2019 Oct; 1720():146302. PubMed ID: 31226325
[TBL] [Abstract][Full Text] [Related]
50. Malignant spinal cord compression in cerebral glioblastoma multiforme: a multicenter case series and review of the literature.
Tinchon A; Oberndorfer S; Marosi C; Rudà R; Sax C; Calabek B; Grisold W
J Neurooncol; 2012 Nov; 110(2):221-6. PubMed ID: 22886532
[TBL] [Abstract][Full Text] [Related]
51. Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study.
Mohammed S; Dinesan M; Ajayakumar T
Rep Pract Oncol Radiother; 2022; 27(6):1026-1036. PubMed ID: 36632307
[TBL] [Abstract][Full Text] [Related]
52. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
Rezaei V; Rabiee A; Khademi F
J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic pathways and glioblastoma treatment.
Clarke J; Penas C; Pastori C; Komotar RJ; Bregy A; Shah AH; Wahlestedt C; Ayad NG
Epigenetics; 2013 Aug; 8(8):785-95. PubMed ID: 23807265
[TBL] [Abstract][Full Text] [Related]
54. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
55. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
56. A narrative review of research progress on drug therapies for glioblastoma multiforme.
Zheng X; Tang Q; Ren L; Liu J; Li W; Fu W; Wang J; Du G
Ann Transl Med; 2021 Jun; 9(11):943. PubMed ID: 34350258
[TBL] [Abstract][Full Text] [Related]
57. Postoperative treatment of glioblastoma multiforme with radiation therapy plus concomitant and adjuvant temozolomide : A mono-institutional experience of 215 patients.
Julka PK; Sharma DN; Mallick S; Gandhi AK; Joshi N; Rath GK
J Cancer Res Ther; 2013; 9(3):381-6. PubMed ID: 24125970
[TBL] [Abstract][Full Text] [Related]
58. The molecular biology and immunology of glioblastoma multiforme (GBM) with the presentation of an immunotherapy protocol for a clinical trial.
Sinkovics JG; Horvath JC
Acta Microbiol Immunol Hung; 2006 Dec; 53(4):367-429. PubMed ID: 17278710
[TBL] [Abstract][Full Text] [Related]
59. Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme.
England B; Huang T; Karsy M
Tumour Biol; 2013 Aug; 34(4):2063-74. PubMed ID: 23737287
[TBL] [Abstract][Full Text] [Related]
60. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Sintupisut N; Liu PL; Yeang CH
Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]